ast2818

Alflutinib (Firmonertinib) is an inhibitor of EGFR, and its targets including EGFR activating mutations and T790M, thus leading to tumor growth inhibition.

Alflutinib mesylate (AST2818 mesylate) ,is an irreversible tyrosine kinase inhibitor that selectively inhibits EGFR mutations, especially T790M.

AST5902 trimesylate is the primary metabolite of Alflutinib (AST2818) both in vivo and in vitro. It exhibits antitumor activity. Alflutinib functions as an EGFR inhibitor.

Alflutinib mesylate (Standard) is a reference standard for research and analysis in studies involving Alflutinib mesylate. Alflutinib mesylate (AST2818 mesylate) ,is an irreversible tyrosine kinase inhibitor that selectively inhibits EGFR mutations, especially T790M.